1 Succinimide derivatives can be either convulsant (tetramethylsuccinimide (TMS)), or anticonvulsant (ethosuximide (ES); a-methyl-a-phenylsuccinimide (MPS) 
Introduction
Spike-wave discharges, the electroencephalographic hallmark of petit mal seizures, are thought to result from an underlying oscillatory interaction between reciprocally connected thalamic and cortical neuronal populations in both animal models of petit mal (Avoli et al., 1983; Gloor & Fariello, 1988; Vergnes et al., 1987) , and in man with this form of epilepsy (Williams, 1953) . Virtually all thalamic neurones are endowed with a prominent low-threshold calcium conductance that is of sufficient magnitude to generate a low-threshold calcium spike (Deschenes et al., 1984; Jahnsen & Llina.s, 1984a,b; Coulter et al., 1989c) . This conductance is important in the generation of normal thalamocortical oscillations such as sleep spindles (reviewed in Steriade & Llinas, 1988) , and may also play a key role in the development of spike-wave discharges of petit mal (see Coulter et al., 1989b for review). We have proposed that reductions in this calcium current in thalamic neurones might be one mechanism by which the thalamocortical oscillatory interaction underlying petit mal epilepsy could be dampened or blocked by anticonvulsant drugs (Coulter et al., 1989ab) . Ethosuximide (ES; structure illustrated in Figure 1 ) is an agent widely used in treatment of petit mal (Browne et al., 1975) . Previous results from this laboratory have shown that ES, but not succinimide, the unsubstituted, clinically inactive ring base of ES (Ferrendelli & Kupferberg, 1980) , specifically reduces the low-threshold calcium current (LTCC) underlying the low-threshold calcium spike in thalamic neurones (Coulter et al., 1989a,b) . A structurally similar petit mal anticonvulsant, dimethadione (DMD), also reduced LTCC in thalamic neurones, when applied in clinically relevant concentrations (Coulter et al., 1989ab ; Figure 1 ).
The reduction of LTCC in thalamic neurones may thus be a cellular mechanism by which ES and DMD control petit mal seizures. In order to test this hypothesis further, we have examined the actions of ES, two other succinimides (a-methyla-phenyl succinimide, an anticonvulsant, MPS; Figure 1 ), tetramethylsuccinimide (TMS, a convulsant; Figure 1 ) and the Author for correspondence.
convulsant pentylenetetrazol (PTZ) on calcium currents and, in an accompanying paper (Coulter et al., 1990) , on yaminobutyric acid (GABA)ergic responsiveness of thalamic neurones. The convulsant action of the a-, fl-substituted succinimide, TMS (Klunk et al., 1982c) , may be due to its reduction of GABAergic responsiveness in cortical neurones (Barnes & Dichter, 1984) . A similar mechanism may be responsible for the convulsant action of PTZ (Nicoll & Padjen, 1976; Macdonald & Barker, 1977 Ltd, 1990 anticonvulsants (LUscher & Schmidt, 1988) . We were therefore interested in the effects and interactions of petit mal anticonvulsants on calcium currents and on GABA responses of thalamic neurones (Coulter et al., 1990) .
We hypothesized that TMS and PTZ should exhibit low potency in reducing LTCC (a proposed petit mal anticonvulsant action) and higher potency in blocking GABAergic responsiveness (a proposed convulsant action), while MPS should reduce LTCC in clinically relevant concentrations (as does ES), and exhibit lower potency as a blocker of GABAergic responsiveness (as should ES). These spectra of action are supported by the results presented here, and in the accompanying paper (Coulter et al., 1990) . In addition, we found that the block of LTCC produced by MPS had many similarities to that produced by ES. The implication of these findings with respect to the potential link between LTCC reduction and petit mal anticonvulsant action is discussed, as is the structure-activity relationship of the LTCC-blocking receptor.
Methods

Dissociation
All experiments were performed on thalamic neurones isolated from the ventrobasal nucleus of young rats (age 1-15 days) with methods described by Kay & Wong (1986) (Forscher & Oxford, 1985; Mody et al., 1988) . This maintenance solution was used to fill the shank of the electrode, but was omitted from the solution which was used to back-fill the tip of the electrode, because it was found that gigaohm seals were difficult to obtain with protein in the tip solution. The external solution contained (in mm): NaCl 155, KCI 3, MgCI2 1, CaCl2 3, HEPES-Na+ 10 and tetrodotoxin 0.0005; pH 7.4. All recordings were obtained at room temperature (20-220C (Coulter et al., 1989c) .
Drug concentrations and method ofapplication
MPS is an N-demethylated active metabolite of methsuximide (Celontin, Parke Davis) (Strong et al., 1974; Porter et al., 1979) that is effective in the control of petit mal epilepsy. It is more toxic than ES (Chen et al., 1963) , but has a broader spectrum of action, being also effective against complex partial seizures (Wilder & Buchanan, 1981; Browne et al., 1983) . Clinically relevant free serum concentrations of MPS are in the range of 50-250uM (Strong et al., 1974; Porter et al., 1979), while those for ES have been found to be 250-750juM (Browne et al., 1975 However, TMS reduces GABAergic responses by 60-80% at 0.5-1 mm in cultured cortical neurones (Barnes & Dichter, 1984) , and therefore we applied the drug concentrations of 10pM to 10mM. ES and TMS were readily soluble in the perfusion medium. MPS often required sonication to speed solubilization. All drugs were bath applied.
Results
Calcium currents
Under voltage-clamp conditions, with internal and external ionic composition designed to isolate calcium currents (see Methods), depolarizing voltage commands elicit at least two distinct calcium currents in thalamic neurones, which differ both in their kinetics, and sensitivity to pharmacological blockers (Coulter et al., 1989c) . Small depolarizing commands from a holding potential of -100 mV evoked a transient, fully inactivating current that could be seen in isolation (e.g. Figure  2a ). This current had a threshold of approximately -65 mV. Larger amplitude depolarizing commands elicited a highthreshold, sustained component of calcium current (HTCC), with a threshold of approximately -30mV ( Figure 2b ). The HTCC peaked in amplitude during step commands to OmV (e.g. Figure 2b and c), and varied little in magnitude when evoked from holding potentials of -I00 mV or -30mV (see Coulter et al., 1989c) . By contrast, the low threshold, transient calcium current (LTCC) showed complete steady-state inactivation at potentials of -65 mV or more depolarized, and was half-inactivated at -83 mV, on average (Coulter et al., 1989c) . As in other neurones (Fox et al., 1987; Narahashi et al., 1987) , the LTCC and HTCC were differentially blocked by divalent cations, with the LTCC being more sensitive to Ni2+, and the HTCC to Cd2+ (Coulter et al., 1989c) . Therefore, the LTCC appears analogous to the 'T' current (Fox et al., 1987) , 'type I' current (Narahashi et al., 1987) or the 'l.v.a.' current (Carbone & Lux, 1984) described by others while the HTCC has properties similar to the 'L' current (Fox et al., 1987) , 'type II' current (Narahashi et al., 1987) , or the 'h.v.a.' current (Carbone & Lux, 1984) .
Drug effects on calcium currents
The actions of drugs on calcium currents were examined in 77 neurones. reduced the LTCC in all neurones to which it was applied (n = 55). In higher concentrations (> 500pM), it reduced the high threshold calcium current (HTCC) as well. centration. Figure 3 illustrates the effects of bath application of 800pM MPS on calcium currents in another neurone. At this concentration, MPS reduced both the LTCC (Figure 3a ) and the HTCC (Figure 3b ). This effect is also shown graphically in Figure 3b . The reductions of LTCC produced by MPS were strongly influenced by the command potential used to elicit the current. This voltage-dependence is illustrated in Figure 5 . Figure 5a shows the reduction of LTCC elicited in response to varying voltage commands from -70 to -35 mV (holding potential = -102 mV) in a cell exposed to 800pM MPS. The LTCC was elicited in isolation over this range of voltage commands (Figures 2 and 3 MPS concentration (>M) Figure 7 illustrates the effect of 1 mM MPS and TMS, on LTCC in the same neurone. MPS clearly reduced the LTCC in a reversible manner, while TMS had little or no effect on the LTCC at 1 mm. In addition, Figure 7 shows Figure 6a . MPS exposure did not alter the voltage-dependence of steady-state inactivation, although it reduced the peak amplitude of the LTCC. Figure   6b illustrates a plot of the average fraction of LTCC available to be activated (relative to the maximal LTCC under control and drug-exposed conditions) vs the holding potential from which the LTCC was evoked, for 4 cells to which MPS (800pM) was bath applied, and shows that drug application had no effect on steady-state inactivation of the LTCC relative to control. In addition, lower, clinically relevant concentrations of MPS were also without effect (not shown).
Many aspects of MPS reduction of LTCC are similar to those previously demonstrated for ES (Coulter et al., 1989b) . We therefore compared the effects of these two agents (in equivalent concentrations) on calcium currents in 6 cells. In this group of neurones, 500pM ES or MPS reduced LTCC by 23.4 + 2.7% and 27.6 + 3.6%, respectively. By contrast in 14 cells, the convulsant succinimide TMS had little effect on LTCC at concentrations of 1 mm or less (0% reduction at 100 juM, 4.4 + 2.0% reduction at 1 mM, in 4 cells to which concentrations of 100,pM, 1 mm, and 10mM TMS were applied).
Discussion
We previously demonstrated that both ES and DMD, structurally similar petit mal anticonvulsants (Figure 1 ), reduce LTCC in thalamic neurones when applied in clinically relevant concentrations (Coulter et al., 1989ab) . The clinically inactive ring base of ES, succinimide, had no effect on the LTCC at equivalent concentrations (Coulter et al., 1989a Thalamic neurones are thought to participate in the oscillatory thalamocortical discharge underlying the 3Hz spikewave rhythms of petit mal. The low-threshold calcium spike, which is generated by the LTCC (Coulter et al., 1989c) and is ubiquitous in thalamic neurones, has been implicated as important in the generation and maintenance of thalamocortical oscillatory interactions (reviewed in Steriade & Llinas, 1988) . The reduction in LTCC produced by ES, MPS, and DMD therefore appears compatible with the anticonvulsant activity of these compounds (i.e. they may depress the pathological thalamocortical rhythm underlying the spike-wave discharges through their effects on LTCC). The lack of effect of the inactive and convulsant succinimides, succinimide and TMS, on LTCC also appears consistent with this conclusion.
MPS-induced reduction of LTCC is similar in many respects to ES reduction of the same conductance. Like ES, MPS reduces LTCC without affecting the time course of the current (Coulter et al., 1989b) , suggesting that the LTCC reduction is accomplished without either slowing activation or speeding inactivation (Figure 2ab ). The actions of MPS and ES occur without effects on the voltage-dependence of steadystate inactivation (Figure 6; Coulter et al., 1989b) , and both agents reduce LTCC in a similar voltage-dependent manner, with maximal effects at the voltage threshold for eliciting the current (Figure 5; Coulter et al., 1989b) . Such voltagedependence would increase the effectiveness of these drugs in vivo, by reducing the LTCC maximally when it is elicited by small depolarizations, as would occur at the onset of spindle waves (Steriade & Llinas, 1988) and probably during spike wave discharges (SWD). In a positive feedback circuit such as the thalamocortical loop underlying the spike-and-wave discharge of petit mal, this kind of action would be very effective either at blocking the onset of the discharge, or severely curtailing the full expression of the oscillations responsible for the epileptic attack.
There were also some interesting differences between the actions of ES and MPS. ES reduced LTCC with greater potency, but lower efficacy than MPS (the IC50 for ES was 200pM vs 1100pM for MPS and the maximal effects were 40% and 100% reductions for ES and MPS, respectively (Coulter et al., 1989b; Figure 2c in reducing calcium currents. ES selectively reduced LTCC, rarely affecting the HTCC at any concentration (Coulter et al., 1989a,b) , while MPS had a selective action on LTCC at clinically relevant concentrations (200p1M or less, Figure 3a ,b) but reduced the HTCC as well at higher concentrations ( Figure  3c ). This effect of higher concentrations of MPS was similar to that of DMD (Coulter et al., 1989ab Evidence from these experiments and other studies provides insight into the structural aspects of the receptor that mediates LTCC reduction. ES and MPS (both a-substituted succinimides, Figure 1 ) reduce LTCC at concentrations less than 1 mm, while succinimide (the unsubstituted ring base of ES and MPS) does not (Coulter et al., 1989a) Figure  7) , it is unlikely that TMS even binds to any significant degree to the receptor at 1 mm concentration. Therefore, asubstitution appears necessary for activity at the LTCCreducing receptor, while fl-substitution reduces effectiveness.
DMD and phenytoin also reduce the LTCC (Twombly et al. 1988; Coulter et al., 1989a,b) . These molecules are similar to ES and MPS in that they are substituted 5-membered heterocyclic rings with two carbonyl carbons bordering a nitrogen, but they differ in their ring closure (-N-for phenytoin, -0-for DMD, vs -CH2-for the succinimides, Figure 1 ). This suggests that there is some nonselectivity on the part of the receptor in terms of the ring closure, and ring shape of agonists. One prediction from this is that certain barbiturates, including phenobarbitone, which are structurally similar to the active succinimides (particularly to MPS, Figure 1 ) might be active at the LTCC-reducing site. This prediction is currently being tested.
Many characteristics of this LTCC-reducing receptor are similar to those of a receptor responsible for anticonvulsant activity described by Ferrendelli and colleagues (Klunk et al., 1982c) . In their studies of alkyl-substituted butyrolactones and succinimides, these investigators showed that a-substitution alone resulted in significant anticonvulsant activity (Klunk et al., 1982b) , while a-and /1-or y-(for the butyrolactones) substitution resulted in convulsant activity (Klunk et al., 1982a) . The order of potency of the various succinimides in reducing LTCC is ES > MPS > TMS, while the order of potency for these same compounds in reducing GABAergic responsiveness is TMS > ES > MPS (Coulter et al., 1990) . The receptor mediating the LTCC-reducing action (as discussed above) appears to be distinct from the picrotoxin receptor, hypothesized by Klunk et al. (1982c) mechanism, GABAergic blockade (Nicoll & Padjen, 1976; Macdonald & Barker, 1977) , did not affect LTCC in concentrations up to 10mm, and so its convulsant actions cannot be attributed even partially to actions on thalamic calcium cur--42 mV -102 mVj Control TMS 1 mM MPS 1 mm rents. These findings have important implications related to the use of PTZ-induced seizures as a screen for testing potential petit mal anticonvulsants, and are further discussed in the succeeding paper (Coulter et al., 1990) .
The LTCC reducing effects of MPS do not explain its anticonvulsant spectrum of action, since this drug is effective against both petit mal and other seizure types, whereas ES, with essentially the same action on LTCC, is selectively effective in petit mal absence. MPS is structurally intermediate between ES and phenytoin in that it has both alkyl and phenyl substitutions at what corresponds to the a-position on a heterocyclic-5-memrbered ring (Figure 1) . Phenytoin is known to reduce sustained repetitive firing (reviewed in Macdonald & McLean, 1986) , and to shift steady-state inactivation of the sodium current (Willow et al., 1985) , actions which may underlie its anticonvulsant effects against partial complex and generalized motor seizures (Macdonald & McClean, 1986) . These actions of phenytoin, together with the structural similarities between MPS and phenytoin, lead to the hypothesis that the broader spectrum of action of MPS versus ES might be due to effects of the former drug on sodium currents.
One interesting consequence of the hypothesis that thalamic low-threshold calcium spikes are involved in generation of spike-wave discharge is that drugs which specifically block the LTCC and cross the blood/brain barrier might be expected to exhibit petit mal anticonvulsant activity. Various alcohols, including menthol (Swandulla et al., 1987) ; and octanol (Llinas & Yarom, 1986) have been shown to block LTCC in different neuronal preparations. However, this block is not specific, in that the HTCC is also reduced (Swandulla et al., 1987; Twombly & Narahashi, 1989) . It also remains to be determined whether these alcohols have added effects on other ion channels, and/or on membrane fluidity. Another interesting family of drugs which might have anticonvulsant activity are amiloride and related compounds. These agents specifically block LTCC in mouse neuroblastoma and chick dorsal root ganglion neurones (Tang et al., 1988) . However, other actions include inhibition of the Na+/H' and Na+/Ca2+ exchange systems (Kinsella & Aronson, 1981; Schellenberg et al., 1983) , and blockade of the tetrodotoxin-insensitive Na+ channel in epithelial cells (Palmer, 1984) . Also, the positive charge on amiloride at physiological pH should prevent the drug from crossing the blood/brain barrier. It may be possible to develop analogues of amiloride, or entirely new compounds, which will cross the blood/brain barrier, block LTCC, and prove effective as anticonvulsants.
The finding that petit mal anticonvulsant succinimides ES and MPS, but not convulsant (TMS) and inactive succinimides (succinimide), reduce the LTCC in thalamic neurones in clinically relevant concentrations lends strong support to the idea that this cellular action is related to the clinical effectiveness of these agents as anticonvulsants. This idea is further supported by the finding that the convulsant PTZ was without effect on calcium currents in concentrations up to 10mM. Figure 7 Effects of tetramethylsuccinimide (TMS), methylphenylsuccinimide (MPS) and MPS plus TMS on the low-threshold calcium current (LTCC) in one neurone. Sweeps illustrating the amplitude of LTCC in control, 1 mM TMS, 1 mM MPS, 1 mM TMS plus 1 mM MPS and 1 mM TMS again, and wash conditions. TMS had little or no effect on LTCC at 1 mn, and did not occlude MPS reductions of LTCC when applied concurrently. All currents were elicited by a step command to -42 mV from a holding potential of -102 mV. The dotted line is included to aid comparison between sweeps.
